Differentiating Albinism from other diseases: Difference between revisions

Jump to navigation Jump to search
Line 127: Line 127:
* [[Nystagmus ]]
* [[Nystagmus ]]
* [[Night blindness]]
* [[Night blindness]]
|-
| style="background:#DCDCDC;" align="center" + | [[Aniridia]]
| style="background:#F5F5F5;" + | -
| style="background:#F5F5F5;" + | -
| style="background:#F5F5F5;" + |
* Absence of the [[iris]]
* [[Foveal hypoplasia]]
* [[nystagmus]]
* [[Amblyopia]]
* [[cataracts]]
|-
| style="background:#DCDCDC;" align="center" + | [[Congenital]] [[nystagmus]]
| style="background:#F5F5F5;" + | [[X-linked]] disorder
| style="background:#F5F5F5;" + | FRMD7 gene mutation
| style="background:#F5F5F5;" + |
* [[Nystagmus]]
* Reduced [[visual acuity]]
|-
|-
|}
|}

Revision as of 23:12, 23 August 2021

Albinism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Albinism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating Albinism from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating Albinism from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating Albinism from other diseases

CDC on Differentiating Albinism from other diseases

Differentiating Albinism from other diseases in the news

Blogs on Differentiating Albinism from other diseases

Directions to Hospitals Treating Albinism

Risk calculators and risk factors for Differentiating Albinism from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Differential Diagnosis

Differential diagnosis of Albinism
Disease Inheritance Gene mutation Diagnostic criteria
Hermansky-Pudlak syndrome Autosomal recessive Affected genes of lysosome-related organelles
Chediak-Higashi syndrome Autosomal recessive Lysosomal trafficking regulator gene
Griscelli syndrome Autosomal recessive Defects in myosin, myosin receptors, and binding
Waardenburg syndrome type II Autosomal dominant MITF gene mutation
Vici syndrome Autosomal recessive Mutation in ectopic P granules protein 5
Tietz albinism-deafness syndrome Autosomal dominant MITF gene mutation
Angelman syndrome Loss of the maternal copy of chromosome 15q11.2-13 -
Prader-Willi syndrome Loss of the paternal copy of chromosome 15q11.2-13 -
Cross-McKusick-Breen syndrome Autosomal recessive De novo interstitial deletion of (3)(q27.1q29) of the paternal chromosome
Achromatopsia Autosomal recessive Dysfunctional cone cells in the retina
Aland Island eye disease (Forsius-Eriksson syndrome) X-linked recessive Novel CACNA1F gene mutation
Aniridia - -
Congenital nystagmus X-linked disorder FRMD7 gene mutation

References

  1. "Albinism - StatPearls - NCBI Bookshelf".
  2. Lee ST, Nicholls RD, Bundey S, Laxova R, Musarella M, Spritz RA (1994). "Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism". N Engl J Med. 330 (8): 529–34. doi:10.1056/NEJM199402243300803. PMID 8302318.
  3. HERMANSKY F, PUDLAK P (1959). "Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies". Blood. 14 (2): 162–9. PMID 13618373.
  4. DePinho RA, Kaplan KL (1985). "The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations". Medicine (Baltimore). 64 (3): 192–202. PMID 3921802.
  5. Witkop CJ, Nuñez Babcock M, Rao GH, Gaudier F, Summers CG, Shanahan F; et al. (1990). "Albinism and Hermansky-Pudlak syndrome in Puerto Rico". Bol Asoc Med P R. 82 (8): 333–9. PMID 2261023.
  6. Dimson O, Drolet BA, Esterly NB (1999). "Hermansky-Pudlak syndrome". Pediatr Dermatol. 16 (6): 475–7. doi:10.1046/j.1525-1470.1999.00122.x. PMID 10632950.
  7. Fukai K, Ishii M, Kadoya A, Chanoki M, Hamada T (1993). "Chédiak-Higashi syndrome: report of a case and review of the Japanese literature". J Dermatol. 20 (4): 231–7. doi:10.1111/j.1346-8138.1993.tb03867.x. PMID 8315113.
  8. Mancini AJ, Chan LS, Paller AS (1998). "Partial albinism with immunodeficiency: Griscelli syndrome: report of a case and review of the literature". J Am Acad Dermatol. 38 (2 Pt 2): 295–300. doi:10.1016/s0190-9622(98)70568-7. PMID 9486701.
  9. WAARDENBURG PJ (1951). "A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness". Am J Hum Genet. 3 (3): 195–253. PMC 1716407. PMID 14902764.

Template:WS Template:WH